The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000957392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
9/07/2026
Date registered
Help: Date registered
4/08/2026
Date last updated
Help: Date last updated
4/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
4/08/2026
Date results provided
Help: Date results provided
4/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Parenting program for early development of children from ethnic minority groups in Lai Chau: a cluster randomised controlled trial of effectiveness
Scientific title
Evaluation of the effectiveness of the Early Journey of Life Program adapted for ethnic minority groups for child development in Lai Chau: a cluster randomised controlled trial
Additional trial identifiers [1] 317516 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records
ACTRN12617000442303 - original trial
The Early Journey of Life (EJoL) intervention that is to be investigated in this current trial is based on the community-based multicomponent parenting intervention, Learning Clubs, which was tested in the original cluster Randomised Controlled Trial.

ACTRN12625001113448 - follow-up study of original trial.
This study is following-up the parents and child that participated in the original trial.

Health condition
Health condition(s) studied:
Child cognitive development 342256 0
Maternal mental health 342258 0
Maternal experience of intimate partner violence 342259 0
Perinatal common mental disorders among women 342260 0
Condition category
Condition code
Public Health 338370 338370 0 0
Health promotion/education
Mental Health 338371 338371 0 0
Studies of normal psychology, cognitive function and behaviour
Reproductive Health and Childbirth 338372 338372 0 0
Antenatal care
Reproductive Health and Childbirth 338373 338373 0 0
Childbirth and postnatal care

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The Early Journey of Life (EJoL) intervention is based on the community-based multicomponent parenting intervention, Learning Clubs, which was tested in rural Ha Nam (ACTRN12617000442303). To scale EJoL and promote feasible and sustainable implementation it was integrated into the National Expanded Program on Immunization (NEPI). The parenting group sessions are now delivered following routine immunizations in selected provinces.
To ensure the intervention was accessible and culturally appropriate, EJoL underwent a period of community consultation to develop a version that was culturally adapted and accessible in local languages in partnership with national and provincial governments. The EJoL intervention includes twelve practice-based sessions of approximately 30 - 45 minutes delivered over the course of 18 months, covering prenatal care during pregnancy, early learning to support child cognitive development, responsive caregiving, adequate nutrition, health, safety, and hygiene. Two of these twelve sessions are delivered during pregnancy and the remaining ten are delivered to both mother and child post birth. Sessions will take place at commune health centres (CHCs), satellite CHCs, or mobile immunization spots. Participant attendance, adherence, and program coverage will be monitored through standardized checklists.
Commune or village health workers will serve as facilitators, delivering these sessions to small groups of up to 20 caregivers. Facilitators will receive training in two phases, Phase 1 consists of the self-paced e-learning course, 'Early Childhood Care and Development in the First 2,000 Days', which comprises nine modules and requires approximately six hours to complete. Upon completion of Phase 1, facilitators will attend a two day, face to face Phase 2 training workshop. Phase 2 will cover integrating EJoL into immunization services through role playing, communication skills, participant engagement techniques, and quality assurance.
Intervention code [1] 334305 0
Prevention
Intervention code [2] 334308 0
Behaviour
Description of the comparator or control
The control group will receive the usual standard of pregnancy and postpartum health care. This includes free antenatal checks, birth in a medical facility and access to the National Growth Monitoring and Expanded Immunisation Programmes.
Control group
Active

Outcomes
Primary outcome [1] 345681 0
Child cognitive development at 12 months old
Timepoint [1] 345681 0
When child is 12 months old
Secondary outcome [1] 462876 0
Child social-emotional development
Timepoint [1] 462876 0
When child is 12 months old
Secondary outcome [2] 462877 0
Child language development
Timepoint [2] 462877 0
When child is 12 months old
Secondary outcome [3] 462878 0
Child motor development
Timepoint [3] 462878 0
When child is 12 months old
Secondary outcome [4] 462879 0
Child height
Timepoint [4] 462879 0
When child is 12 months old
Secondary outcome [5] 462880 0
Child weight
Timepoint [5] 462880 0
When child is 12 months old
Secondary outcome [6] 462881 0
Child BMI
Timepoint [6] 462881 0
When child is 12 months old
Secondary outcome [7] 462884 0
Breastfeeding practice
Timepoint [7] 462884 0
When child is 12 months old
Secondary outcome [8] 462885 0
Child Healthcare expenditure
Timepoint [8] 462885 0
When child is 12 months old
Secondary outcome [9] 462886 0
Maternal height
Timepoint [9] 462886 0
During pregnancy; 12-months postpartum
Secondary outcome [10] 462887 0
Maternal weight
Timepoint [10] 462887 0
During pregnancy; 12-months postpartum
Secondary outcome [11] 462888 0
Pregnancy characteristics
Timepoint [11] 462888 0
During pregnancy; 12-months postpartum
Secondary outcome [12] 462889 0
Maternal emotional wellbeing
Timepoint [12] 462889 0
During pregnancy; 12-months postpartum
Secondary outcome [13] 462890 0
Parenting practices
Timepoint [13] 462890 0
12-months postpartum
Secondary outcome [14] 462891 0
Intimate partner violence
Timepoint [14] 462891 0
During pregnancy; 12-months postpartum
Secondary outcome [15] 462892 0
Relationship with partner
Timepoint [15] 462892 0
During pregnancy; 12-months postpartum
Secondary outcome [16] 462893 0
Hygiene practices
Timepoint [16] 462893 0
During pregnancy; 12-months postpartum
Secondary outcome [17] 462894 0
Male engagement
Timepoint [17] 462894 0
During pregnancy; 12-months postpartum

Eligibility
Key inclusion criteria
All pregnant women less than 35 weeks gestation living in the selected communes will be eligible to participate. All newborns of pregnant women that completed the pregnancy sessions will be eligible to participate.
Minimum age
No limit
Maximum age
No limit
Sex
Females
Healthy volunteers
No
Key exclusion criteria
Women that are not pregnant or who do not live in the province of Lai Chau will be excluded.

Women with cognitive or physical disabilities that would limit their ability to attend sessions will be excluded, as determined by commune health workers.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
All 38 communes in Lai Chau are eligible and willing to participate. An independent statistician will randomly allocate 19 communes to the intervention and 19 communes to the control group using Stata V.19.0. People analysing outcomes will analyse the data on the basis of there being two groups, but will not know which group is the intervention and which is the control group.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
In 2025, across the 38 communes in Lai Chau the number of pregnant women from the H’mong ethnic group was estimated to be approximately 3,000, which is expected to meet the required sample size. A sample size of 494 pregnant women from 38 communes (cluster units) is needed to detect a standard mean difference of 0.35 in the primary outcome (child cognitive score at 1 year old) between control and intervention groups with 80% statistical power, a significance level of 0.05, an intracluster correlation coefficient of 0.025 and an average cluster size of 10 women. The sample size allows 10% of cluster drop-out and 20% of participants missing data/loss to follow-up or drop-out. These assumptions are based on our previous study and consultations with local authorities. Additionally, a cost-effectiveness analysis will be conducted to assess the economic value of the intervention.
All analyses will follow the intention-to-treat principles. Analyses will be conducted at the individual level using Stata, V.19.0. and SAS 9.4.


Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 28190 0
Viet Nam
State/province [1] 28190 0
Lai Chau Province

Funding & Sponsors
Funding source category [1] 322079 0
Charities/Societies/Foundations
Name [1] 322079 0
The LEGO Foundation
Country [1] 322079 0
Denmark
Funding source category [2] 322080 0
Charities/Societies/Foundations
Name [2] 322080 0
The Human Safety Net
Country [2] 322080 0
Italy
Primary sponsor type
University
Name
Monash Universty
Address
Country
Australia
Secondary sponsor category [1] 324966 0
Other Collaborative groups
Name [1] 324966 0
Research and Training Centre for Community Development
Address [1] 324966 0
Country [1] 324966 0
Viet Nam

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320610 0
Monash University Human Research Ethics Committee
Ethics committee address [1] 320610 0
Ethics committee country [1] 320610 0
Australia
Date submitted for ethics approval [1] 320610 0
08/06/2026
Approval date [1] 320610 0
07/07/2026
Ethics approval number [1] 320610 0
52509

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151046 0
Prof Jane Fisher
Address 151046 0
Monash University Level 4, 553 St Kilda Road, Melbourne VIC 3004
Country 151046 0
Australia
Phone 151046 0
+61 3 9903 0290
Fax 151046 0
Email 151046 0
Contact person for public queries
Name 151047 0
Jane Fisher
Address 151047 0
Monash University Level 4, 553 St Kilda Road, Melbourne VIC 3004
Country 151047 0
Australia
Phone 151047 0
+61 3 9903 0290
Fax 151047 0
Email 151047 0
Contact person for scientific queries
Name 151048 0
Yeji Baek
Address 151048 0
Monash University Level 4, 553 St Kilda Road, Melbourne VIC 3004
Country 151048 0
Australia
Phone 151048 0
+61 3 9903 0066
Fax 151048 0
Email 151048 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Anyone
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor

• Consideration will be given to proposals to use data from the trial for scientifically sound proposals. Formal data sharing agreement will be required and data will be made available through Monash University’s Secure eResearch Platform.

What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Principal investigator
Professor Jane Fisher
[email protected]


Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Other filesNo Approval letter from the Lai Chau Provincial Peopl... [More Details] CV 2487_UBND Lai Chau approved the cRCT_08042026_VIE.pdf

Documents added automatically
No additional documents have been identified.